Histone Deacetylase Inhibitors Market 2027 By Class, Applications | The Insight Partners

Histone Deacetylase Inhibitors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Class ( class I HDACs, class II HDACs, class III HDACs, class IV HDACs ); Applications ( neurology, oncology, others )

Report Code: TIPRE00011773 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Histone deacetylases inhibitors (HDACs) are chemical compounds and a new class of anti-cancer agents. HDACs play an essential role in non-epigenetic and epigenetic regulations that include apoptosis, cell cycle, and death apoptosis. Histone deacetylase inhibitors are emerging compounds with potential applications in prognosis, treatment, and diagnosis of cancer. Also, histone deacetylase inhibitors accumulate acetylated nuclear histone in normal tissues and tumors.

MARKET DYNAMICS

The histone deacetylase inhibitors market is driving due to the rise in prevalence of cancer across the globe resulting in the increase in the need for improved and effective therapies. However, uncertainty issues and inadequate reimbursement for histone deacetylase inhibitors are likely to restrain the global market during the forecast period. Moreover, increase in collaboration among histone deacetylase inhibitors manufacturers and research & development on treatment of cancer and other chronic diseases are expected to propel the global histone deacetylase inhibitors market.

MARKET SCOPE

The "Histone Deacetylase Inhibitors Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of histone deacetylase inhibitors market with detailed market segmentation by of class and application. The histone deacetylase inhibitors market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in histone deacetylase inhibitors market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The histone deacetylase inhibitors market is segmented on the basis of class and application. Based on class, the market is segmented as class I HDACs, class II HDACs, class III HDACs, and class IV HDACs. On the basis of application, the market is categorized as neurology, oncology, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the histone deacetylase inhibitors market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The histone deacetylase inhibitors market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting histone deacetylase inhibitors market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the histone deacetylase inhibitors market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the histone deacetylase inhibitors market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from histone deacetylase inhibitors market are anticipated to have lucrative growth opportunities in the future with the rising demand for histone deacetylase inhibitors in the global market. Below mentioned is the list of few companies engaged in the histone deacetylase inhibitors market.

The report also includes the profiles of key players in histone deacetylase inhibitors market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Acetylon Pharmaceuticals, Inc.
  •   AstraZeneca plc
  •   Celgene Corporation
  •   Celleron Therapeutics Ltd.
  •   Eisai Co., Ltd.
  •   Envivo Pharmaceuticals
  •   Merck & Co.
  •   Novartis International AG
  •   Pfizer, Inc.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Histone Deacetylase Inhibitors Market - By Class
1.3.2 Histone Deacetylase Inhibitors Market - By Applications
1.3.3 Histone Deacetylase Inhibitors Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HISTONE DEACETYLASE INHIBITORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HISTONE DEACETYLASE INHIBITORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HISTONE DEACETYLASE INHIBITORS MARKET - GLOBAL MARKET ANALYSIS
6.1. HISTONE DEACETYLASE INHIBITORS - GLOBAL MARKET OVERVIEW
6.2. HISTONE DEACETYLASE INHIBITORS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HISTONE DEACETYLASE INHIBITORS MARKET - REVENUE AND FORECASTS TO 2027 - CLASS
7.1. OVERVIEW
7.2. CLASS MARKET FORECASTS AND ANALYSIS
7.3. CLASS I HDACS
7.3.1. Overview
7.3.2. class I HDACs Market Forecast and Analysis
7.4. CLASS II HDACS
7.4.1. Overview
7.4.2. class II HDACs Market Forecast and Analysis
7.5. CLASS III HDACS
7.5.1. Overview
7.5.2. class III HDACs Market Forecast and Analysis
7.6. CLASS IV HDACS
7.6.1. Overview
7.6.2. class IV HDACs Market Forecast and Analysis
8. HISTONE DEACETYLASE INHIBITORS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. NEUROLOGY
8.3.1. Overview
8.3.2. neurology Market Forecast and Analysis
8.4. ONCOLOGY
8.4.1. Overview
8.4.2. oncology Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. others Market Forecast and Analysis
9. HISTONE DEACETYLASE INHIBITORS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Histone Deacetylase Inhibitors Market Overview
9.1.2 North America Histone Deacetylase Inhibitors Market Forecasts and Analysis
9.1.3 North America Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Class
9.1.4 North America Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Applications
9.1.5 North America Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Countries
9.1.5.1 United States Histone Deacetylase Inhibitors Market
9.1.5.1.1 United States Histone Deacetylase Inhibitors Market by Class
9.1.5.1.2 United States Histone Deacetylase Inhibitors Market by Applications
9.1.5.2 Canada Histone Deacetylase Inhibitors Market
9.1.5.2.1 Canada Histone Deacetylase Inhibitors Market by Class
9.1.5.2.2 Canada Histone Deacetylase Inhibitors Market by Applications
9.1.5.3 Mexico Histone Deacetylase Inhibitors Market
9.1.5.3.1 Mexico Histone Deacetylase Inhibitors Market by Class
9.1.5.3.2 Mexico Histone Deacetylase Inhibitors Market by Applications
9.2. EUROPE
9.2.1 Europe Histone Deacetylase Inhibitors Market Overview
9.2.2 Europe Histone Deacetylase Inhibitors Market Forecasts and Analysis
9.2.3 Europe Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Class
9.2.4 Europe Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Applications
9.2.5 Europe Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Histone Deacetylase Inhibitors Market
9.2.5.1.1 Germany Histone Deacetylase Inhibitors Market by Class
9.2.5.1.2 Germany Histone Deacetylase Inhibitors Market by Applications
9.2.5.2 France Histone Deacetylase Inhibitors Market
9.2.5.2.1 France Histone Deacetylase Inhibitors Market by Class
9.2.5.2.2 France Histone Deacetylase Inhibitors Market by Applications
9.2.5.3 Italy Histone Deacetylase Inhibitors Market
9.2.5.3.1 Italy Histone Deacetylase Inhibitors Market by Class
9.2.5.3.2 Italy Histone Deacetylase Inhibitors Market by Applications
9.2.5.4 Spain Histone Deacetylase Inhibitors Market
9.2.5.4.1 Spain Histone Deacetylase Inhibitors Market by Class
9.2.5.4.2 Spain Histone Deacetylase Inhibitors Market by Applications
9.2.5.5 United Kingdom Histone Deacetylase Inhibitors Market
9.2.5.5.1 United Kingdom Histone Deacetylase Inhibitors Market by Class
9.2.5.5.2 United Kingdom Histone Deacetylase Inhibitors Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Histone Deacetylase Inhibitors Market Overview
9.3.2 Asia-Pacific Histone Deacetylase Inhibitors Market Forecasts and Analysis
9.3.3 Asia-Pacific Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Class
9.3.4 Asia-Pacific Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Histone Deacetylase Inhibitors Market
9.3.5.1.1 Australia Histone Deacetylase Inhibitors Market by Class
9.3.5.1.2 Australia Histone Deacetylase Inhibitors Market by Applications
9.3.5.2 China Histone Deacetylase Inhibitors Market
9.3.5.2.1 China Histone Deacetylase Inhibitors Market by Class
9.3.5.2.2 China Histone Deacetylase Inhibitors Market by Applications
9.3.5.3 India Histone Deacetylase Inhibitors Market
9.3.5.3.1 India Histone Deacetylase Inhibitors Market by Class
9.3.5.3.2 India Histone Deacetylase Inhibitors Market by Applications
9.3.5.4 Japan Histone Deacetylase Inhibitors Market
9.3.5.4.1 Japan Histone Deacetylase Inhibitors Market by Class
9.3.5.4.2 Japan Histone Deacetylase Inhibitors Market by Applications
9.3.5.5 South Korea Histone Deacetylase Inhibitors Market
9.3.5.5.1 South Korea Histone Deacetylase Inhibitors Market by Class
9.3.5.5.2 South Korea Histone Deacetylase Inhibitors Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Histone Deacetylase Inhibitors Market Overview
9.4.2 Middle East and Africa Histone Deacetylase Inhibitors Market Forecasts and Analysis
9.4.3 Middle East and Africa Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Class
9.4.4 Middle East and Africa Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Histone Deacetylase Inhibitors Market
9.4.5.1.1 South Africa Histone Deacetylase Inhibitors Market by Class
9.4.5.1.2 South Africa Histone Deacetylase Inhibitors Market by Applications
9.4.5.2 Saudi Arabia Histone Deacetylase Inhibitors Market
9.4.5.2.1 Saudi Arabia Histone Deacetylase Inhibitors Market by Class
9.4.5.2.2 Saudi Arabia Histone Deacetylase Inhibitors Market by Applications
9.4.5.3 U.A.E Histone Deacetylase Inhibitors Market
9.4.5.3.1 U.A.E Histone Deacetylase Inhibitors Market by Class
9.4.5.3.2 U.A.E Histone Deacetylase Inhibitors Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Histone Deacetylase Inhibitors Market Overview
9.5.2 South and Central America Histone Deacetylase Inhibitors Market Forecasts and Analysis
9.5.3 South and Central America Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Class
9.5.4 South and Central America Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Histone Deacetylase Inhibitors Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Histone Deacetylase Inhibitors Market
9.5.5.1.1 Brazil Histone Deacetylase Inhibitors Market by Class
9.5.5.1.2 Brazil Histone Deacetylase Inhibitors Market by Applications
9.5.5.2 Argentina Histone Deacetylase Inhibitors Market
9.5.5.2.1 Argentina Histone Deacetylase Inhibitors Market by Class
9.5.5.2.2 Argentina Histone Deacetylase Inhibitors Market by Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HISTONE DEACETYLASE INHIBITORS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HISTONE DEACETYLASE INHIBITORS MARKET, KEY COMPANY PROFILES
12.1. ACETYLON PHARMACEUTICALS, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CELGENE CORPORATION
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CELLERON THERAPEUTICS LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. EISAI CO., LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ENVIVO PHARMACEUTICALS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK AND CO.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS INTERNATIONAL AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Acetylon Pharmaceuticals, Inc.
2. AstraZeneca plc
3. Celgene Corporation
4. Celleron Therapeutics Ltd.
5. Eisai Co., Ltd.
6. Envivo Pharmaceuticals
7. Merck & Co.
8. Novartis International AG
9. Pfizer, Inc.
TIPRE00011773
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking